Healthcare -
Biotechnology - NASDAQ - US
$ 3.345
1.36 %
$ 634 M
Market Cap
-7.78
P/E
ABUS - CAPITAL EXPENDITURES
Capital Expenditures ABUS - Arbutus Biopharma Corporation
-1.01 M
LAST VALUE
-11.62%
2 YEAR CAGR
2.40%
5 YEAR CAGR
-3.35%
10 YEAR CAGR